These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1324483)

  • 1. [The use of highly purified glucomannan-based fibers in childhood obesity].
    Livieri C; Novazi F; Lorini R
    Pediatr Med Chir; 1992; 14(2):195-8. PubMed ID: 1324483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glucomannan on obese patients: a clinical study.
    Walsh DE; Yaghoubian V; Behforooz A
    Int J Obes; 1984; 8(4):289-93. PubMed ID: 6096282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic use of glucomannan in the dietary treatment of severe obesity].
    Vita PM; Restelli A; Caspani P; Klinger R
    Minerva Med; 1992 Mar; 83(3):135-9. PubMed ID: 1313163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood obesity treatment: double blinded trial on dietary fibres (glucomannan) versus placebo.
    Vido L; Facchin P; Antonello I; Gobber D; Rigon F
    Padiatr Padol; 1993; 28(5):133-6. PubMed ID: 8247594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucomannan and obesity: a critical review.
    Keithley J; Swanson B
    Altern Ther Health Med; 2005; 11(6):30-4. PubMed ID: 16320857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of the integration of a habitual diet with glucomannan fiber in hypercholesterolemia. A clinical study in familial and sporadic hyperlipoproteinemia with lipo-proteic phenotype IIa and IIb].
    Fanelli V; Angelico F; Stefanutti C; Calvieri A; Fazio S
    Clin Ter; 1986 Oct; 119(1):17-23. PubMed ID: 3024902
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glucomannan: properties and therapeutic applications].
    González Canga A; Fernández Martínez N; Sahagún AM; García Vieitez JJ; Díez Liébana MJ; Calle Pardo AP; Castro Robles LJ; Sierra Vega M
    Nutr Hosp; 2004; 19(1):45-50. PubMed ID: 14983741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved glucose tolerance and insulin response in obese and diabetic patients on a fiber-enriched diet.
    Kanter Y; Eitan N; Brook G; Barzilai D
    Isr J Med Sci; 1980 Jan; 16(1):1-6. PubMed ID: 6987195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of glucomannan dietary fiber in changes in intestinal habit].
    Marsicano LJ; Berrizbeitia ML; Mondelo A
    G E N; 1995; 49(1):7-14. PubMed ID: 8566676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of data errors and reanalysis of "The effect of glucomannan on body weight in overweight or obese children and adults: a systematic review of randomized controlled trials".
    Zalewski BM; Chmielewska A; Szajewska H; Keithley JK; Li P; Goldsby TU; Allison DB
    Nutrition; 2015; 31(7-8):1056-7. PubMed ID: 26059384
    [No Abstract]   [Full Text] [Related]  

  • 11. Dumping syndrome in children. Diagnosis and effect of glucomannan on glucose tolerance and absorption.
    Kneepkens CM; Fernandes J; Vonk RJ
    Acta Paediatr Scand; 1988 Mar; 77(2):279-86. PubMed ID: 2833060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of moderate energy-restricted diets on the nutritional status of selected minerals in obese women].
    Aguirre ME; Ruz M; Carrasco F; Rebolledo A; Karla A; Codoceo J; Inostroza J
    Arch Latinoam Nutr; 2007 Sep; 57(3):238-47. PubMed ID: 18271402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unchanged iron and copper and increased zinc in the blood of obese children after two hypocaloric diets.
    Di Toro A; Marotta A; Todisco N; Ponticiello E; Collini R; Di Lascio R; Perrone L
    Biol Trace Elem Res; 1997 May; 57(2):97-104. PubMed ID: 9282256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid profiles of obese children and adolescents before and after significant weight loss: differences according to sex.
    Sothern MS; Despinasse B; Brown R; Suskind RM; Udall JN; Blecker U
    South Med J; 2000 Mar; 93(3):278-82. PubMed ID: 10728514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diet-induced changes as risk factors in obese children: arterial pressure, glycoregulation and lipid profile].
    Bueno-Lozano M; Bálsamo A; Cacciari E
    An Esp Pediatr; 1991 Nov; 35(5):335-42. PubMed ID: 1785749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Variability of nutritional status and of the parameters of lipid metabolism in gluten-free diet].
    Ozkan M; Trandafir L; Mîndru E; Moraru E
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):103-7. PubMed ID: 23077880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-inflammatory adipocytokines, oxidative stress, insulin, Zn and Cu: Interrelations with obesity in Egyptian non-diabetic obese children and adolescents.
    Habib SA; Saad EA; Elsharkawy AA; Attia ZR
    Adv Med Sci; 2015 Sep; 60(2):179-85. PubMed ID: 25827128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-year follow-up study of treated obese children in Japan.
    Togashi K; Masuda H; Rankinen T; Tanaka S; Bouchard C; Kamiya H
    Int J Obes Relat Metab Disord; 2002 Jun; 26(6):770-7. PubMed ID: 12037646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients].
    Cairella M; Marchini G
    Clin Ter; 1995 Apr; 146(4):269-74. PubMed ID: 7796558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in concentration of serum adiponectin multimeric forms following weight reduction programme in prepubertal obese children.
    Gajewska J; Weker H; Ambroszkiewicz J; Chełchowska M; Więch M; Laskowska-Klita T
    Med Wieku Rozwoj; 2011; 15(3):298-305. PubMed ID: 22006484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.